Resivant puts Cutiva PLUS into patients as silicone-cyanoacrylate wound closure reaches first clinical use
Cutiva PLUS has completed its first patient cases after Resivant scaled its crosslinked silicone-cyanoacrylate adhesive, moving a 2024-cleared wound-closure system toward broader commercial use.